45
Views
68
CrossRef citations to date
0
Altmetric
Research Article

QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes

, , , , , , , & show all
Pages 323-332 | Published online: 08 Jul 2009

REFERENCES

  • Nelson RG, Pettitt DJ, Carraher MJ, Baird HR, Knowler WC. Effect of proteinuria on mortality in NIDDM. Diabetes 1988; 37: 1499–504.
  • Savage PJ. Cardiovascular complications of dia-betes mellitus: what we know and what we need to know about their prevention. Ann Intern Med 1996; 124: 123–6.
  • Kannel WB, McGee DL. Diabetes and cardio-vascular disease. JAMA 1979; 241: 2035–8.
  • Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski A, Rosner B, Arky RA, Speizer FE, Hennekens CH. A prospective study of maturity— onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151: 1141–8.
  • Sawicki P, Kiwitt S, Bender R, Berger M. The value of QT interval dispersion for identification of total mortality risk in non-insulin-dependent diabetes mellitus. J Intern Med 1998; 243: 49–56.
  • Naas A, Davidson N, Thompson C, Cummings F, Ogston SA, Jung RT, Newton RW, Struthers AD. QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study. Br Med J 1998; 316: 745–6.
  • Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989; 32: 219–26.
  • Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving H-H. Albuminuria and poor glycemic control predicts mortality in NIDDM. Diabetes 1995; 44: 1303–9.
  • Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefevre P, Mathiesen ER, Feldt-Rasmussen B, et al. Micro-albuminuria: an early marker of renal involvement in diabetes. Uremia Invest 1985; 9: 85–95.
  • Blackburn H, Keys A, Simonson E, Rautaharju P, Punsar S. The electrocardiogram in population studies: a classification system. Circulation 1960; 21: 1160–75.
  • Sawicki PT, Dame R, Bender R, Berger M. Prolonged QT interval as a predictor of mortality in diabetic nephropathy. Diabetologia 1996; 39: 77–81.
  • Sivieri R, Veglio M, Chinaglia A, Scaglione P, Cavallo-Perin P. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. Diabetic Med 1993; 10: 920–4.
  • Arildsen H, May 0, Christiansen EH, Damsgaard EM. Increased QT dispersion in patients with insulin-dependent diabetes mellitus. Int J Cardiol 2000; 71: 235–42.
  • Dekker JM, Feskens EJM, Schouten EG, Klootwijk P, Pool J, Kromhout D. QTc duration is associated with levels of insulin and glucose tolerance. Diabetes 1996; 45: 376–80.
  • Glancy JM, Garrott CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet 1995; 345: 945–8.
  • Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unex-pected death in chronic heart failure. Lancet 1994; 343: 327–9.
  • Veglio M, Borra M, Stevens LK, Fuller JH, Perin PC. The relation between QTc interval prolonga-tion and diabetic complications. The EURODIAB IDDM complication study group. Diabetologia 1999; 42: 68–75.
  • Elming H, Holm E, Jun L, Torp-Pedersen C, Kober L, Kircshoff M, Malik M, Camm J. The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mor-tality and morbidity in a population of Danish citizens. Eur Heart J 1998; 19: 1391–400.
  • Fei L, Goldman JH, Prasad K, Keeling PJ, Reardon K, Camm AJ, McKenna WJ. QT disperson and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Eur Heart J 1996; 17: 258–63.
  • Zabel M, Klingenheben T, Franz MR, Hohnloser SH. Assessment of QT disperson for prediction of mortality or arrhythmic events after myocardial infarction. Results of a prospective, long-term follow-up study. Circulation 1998; 97: 2543–50.
  • Tentolouris N, Katsilambros N, Papazachos G, Papadogiannis D, Linos A, Stamboulis E, Papageorgiou K. Corrected QT interval in relation to the severity of diabetic autonomic neuropathy. Eur J Clin Invest 1997; 27: 1049 — 54.
  • Wei K, Dorian P, Newman D, Langer A. Association between QT dispersion and auto-nomic dysfunction in patients with diabetes mellitus. J Am Coll Cardiol 1995; 26: 859–63.
  • Nielsen FS, Rossing P, Bang LE, Svendsen TL, Gall M-A, Smidt UM, Parving H-H. On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy. Diabetes 1995; 44: 783–9.
  • Leonardo F, Fragasso G, Rasano GMC, Pagnotta P, Chierchia SL. Effect of atenolol on QT interval and dispersion in pateints with syndrome X. Am J Cardiol 1997; 80: 789–90.
  • Ikeda T. QT prolongation in type 2 diabetes mellitus treated with glibenclamide. Diabete Metab 1994; 20: 565–7.
  • Hill JA, Friedman PL. Measurement of QT interval and QT dispersion. Lancet 1997; 349: 894 — 5.
  • McLaughlin NB, Campbell RWF, Murray A. Accuracy of four automatic QT measurement techniques in cardiac patients and healthy subjects. Heart 1996; 76: 422–6.
  • van de Loo A, Arendts W, Hohnloser SH. Variability of QT dispersion measurements in the surface electrocardiogram in patients with acute myocardial infarction and in normal sub-jects. Am J Cardiol 1994; 74: 1113–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.